Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001415889-24-029847
Filing Date
2024-12-19
Accepted
2024-12-19 16:12:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13098
  Complete submission text file 0001415889-24-029847.txt   14673
Mailing Address 500 GOLDEN RIDGE ROAD, SUITE 100 GOLDEN CO 80401
Business Address
Wahlstrom Mats (Filed by) CIK: 0001459154 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Subject) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91951 | Film No.: 241563403
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)